Introduction {#S0001}
============

Abdominal pain is a common presenting complaint. It accounts for up to 10% of all patients applying to the emergency department. Many different conditions may cause abdominal pain (endocrinological, haematological, neurological, inflammatory, infectious, non-abdominal, etc.). Nonspecific abdominal pain (NSAP) accounts for 50% of abdominal pain, and different surgical procedures are performed in 13--40% of patients with NSAP \[[@CIT0001]--[@CIT0003]\]. However, these methods are not easy and may cause complications.

Platelets play an important role in inflammation \[[@CIT0004]\]. There are complex interactions (including proinflammatory cytokines, chemokines, platelet and endothelial activation) between inflammation and haemostasis. Inflammation increases procoagulant factors, and coagulation also augments inflammation. Platelets may also trigger inflammation through dendritic cells \[[@CIT0005]\]. Increased mean platelet volume (MPV) was reported in patients with acute myocardial infarction, acute cerebral ischaemia, and transient ischaemic attack \[[@CIT0006]--[@CIT0008]\]. The MPV may be a useful parameter for inflammatory conditions \[[@CIT0009]--[@CIT0011]\].

Aim {#S0002}
===

The aim of this study is to investigate the role of MPV on NSAP admittance to the emergency department.

Material and methods {#S0003}
====================

The study enrolled 330 patients (186 female and 144 male, with mean age 49 ±20 years) with NSAP and 249 patients (144 female and 105 male, with mean age 49 ±19 years), who applied to our emergency service with different aetiology of abdominal pain and enrolled in this retrospective study. Thrombocytopaenia, congenital or acquired platelet dysfunctions, smoking, hypertension, hyperlipidaemia, diabetes mellitus, haematological disease, history of cerebrovascular accident, coronary heart disease, and the use of anti-coagulants and/or anti-platelet drugs were exclusion criteria for this study.

We evaluated patients via medical history, physical examination, complete blood count, biochemistry, direct X-ray, ultrasonography, and computed tomography. Abdominal pain was accepted as NSAP if there was no sign for other aetiology of abdominal pain. All patients gave written, informed consent for the study.

Complete blood count was performed on a Beckman Coulter LH 780 instrument. White blood cell (WBC) and platelet counts, haemoglobin, and MPV levels were evaluated. Quality controls in our laboratory documented good reproducibility of MPV measurements, with intra-assay and inter-assay coefficients of variation ≤ 2.2% on commercial controls. The reference range of this device for MPV was 6.5--11.6 fl.

Statistical analysis {#S20004}
--------------------

The data were evaluated using SPSS (Statistical Package for Social Sciences) 13.0 statistical software. Parameters were compared using Student\'s *t* test, and *p* \< 0.05 was accepted as statistically significant.

Results {#S0005}
=======

The patients with abdominal pain were divided into two groups: NSAP and others. The causes of abdominal pain are summarised in [Table I](#T0001){ref-type="table"}. In both groups, platelet counts were more than 100,000/mm^3^. The NSAP accounts for 56% of complaints of abdominal pain. Demographic and haematological parameters are shown in [Table II](#T0002){ref-type="table"}.

###### 

The causes of abdominal pain (*N* = 579)

  Diagnosis                                                                                                                               Number              Percentage
  --------------------------------------------------------------------------------------------------------------------------------------- ------------------- ------------
  Non-specific abdominal pain                                                                                                             330                 56
  Peptic ulcers                                                                                                                           74                  12.6
  Cystitis                                                                                                                                74                  12.6
  Gastroenteritis                                                                                                                         27                  4.6
  Nephrolithiasis                                                                                                                         25                  4.2
  Inflammatory bowel disease                                                                                                              12                  2
  Due to cancers of colon, pancreas, and gall bladder                                                                                     4 from each group   0.7
  Dysmenorrhoea, gastrointestinal bleeding, cholecystitis, ovarian cancer, acute pancreatitis                                             3 from each group   0.5
  Stomach cancer, umbilical hernia                                                                                                        2 from each group   0.3
  Intra-abdominal intrauterine device familial Mediterranean fever ovarian cyst, pelvic inflammatory disease cirrhosis, vaginal fistula   1 from each group   0.2

###### 

Demographic and laboratory data from the two groups

  Diagnosis              NSAP[\*](#TF0001){ref-type="table-fn"} (*n* = 330)   Others (*n* = 249)   Value of *p*
  ---------------------- ---------------------------------------------------- -------------------- --------------
  Age \[years\]          49 ±20                                               49 ±19               0.832
  Gender (F/M)           186/144                                              144/105              
  Leukocyte \[/mm^3^\]   9673 ±6444                                           9243 ±4847           0.372
  Haemoglobin \[g/dl\]   12.5 ±1.9                                            12.7 ±1.9            0.382
  Platelets \[/mm^3^\]   287866 ±119661                                       291891 ±116291       0.682
  MPV \[fl\]             8.03 ±1.4                                            8.27 ±1.1            0.025

NSAP -- Non-specific abdominal pain.

The MPV values were significant lower in patients with NSAP than in the others (*p* = 0.025). There was no significant difference between both sexes for MPV (*p* \> 0.05). Moreover, the other haematological parameters (haemoglobin, platelet, or WBC counts) were not statistically different between both groups (*p* \> 0.05).

Discussion {#S0006}
==========

In this study, MPV was significantly lower in patients with abdominal pain than in the others. But there was no significant difference for platelet counts between both groups. Increased MPV is associated with increased platelet production in some conditions. The reference value for MPV is accepted as 6--10 fl \[[@CIT0012]\]. It is an indicator for platelet reactivity and function \[[@CIT0005], [@CIT0006]\]. Large platelets are more active (enzymatic and metabolic) than small platelets and produce more thromboxane A2 \[[@CIT0013]\]. Also, MPV is a physiological variable of haemostasis. Larger platelets are denser and contain more a-granules, which can release prothrombotic substances, including platelet factor 4, platelet-derived growth factor, and P-selectin, a chemotactic and mitogenic factor contributing to vascular neointimal proliferation \[[@CIT0006]--[@CIT0008]\]. Although the most precise methodology to measure MPV is still uncertain, it is a routinely available parameter in the outpatient or inpatient setting at a relatively low cost \[[@CIT0007]\]. A positive or negative relationship between MPV and platelet count has been reported in many studies \[[@CIT0008], [@CIT0010]\]. Increased MPV was found in older smoking patients, but not in non-smokers \[[@CIT0014], [@CIT0015]\]. We have no information about MPV or platelet counts in our smoker patients.

The MPVs were 8.9 ±1.4 fl in the healthy population \[[@CIT0016]\]. In our study, MPV values were 8.03 ±1.4 fl in the NSAP group and 8.27 ±1.1 fl in the other group. The most important problem regarding the clinical validity of MPV is that it changes over time as platelets swell in EDTA, with an increase of 7.9% within 30 min and an overall increase of 13.4% over 24 h. However, the majority of this increase occurs in the first 6 h \[[@CIT0017]\]. It is widely accepted that platelet swelling in test tubes can be minimised by rapid processing of samples, i.e. within 1 h \[[@CIT0018]\]. Our study was performed in an emergency service, so whole blood counts were performed within 30 min.

There are many retrospective studies about MPV values in the literature. Özlü *et al*. reported elevated MPV levels in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) compared with control subjects in the young population \[[@CIT0019]\]. Also, increased MPV was established to be an independent predictor of NSTE-ACS in their study \[[@CIT0019]\]. In another study, it was shown that patients with coronary artery ectasia and coronary artery disease have higher MPVs than subjects with normal coronary angiograms \[[@CIT0020]\].

Increased MPVs were reported in patients with obstructive sleep apnoea syndrome (OSAS), and this was related to severity of disease. Also, there is increased inflammation in OSAS \[[@CIT0021]\]. Karaman *et al*. \[[@CIT0022]\] reported lower MPVs in patients with non-functional pancreatic neuroendocrine tumour compared with pancreatic adenocarcinoma. However, many previous studies reported decreased MPV with inflammation. Decreased MPV in patients with active rheumatic arthritis and ankylosing spondylitis was reported \[[@CIT0023]\]. Beyazit *et al*. \[[@CIT0024]\] reported decreased MPV in patients with acute pancreatitis and increased MPV after treatment. The MPV was 7.8 fl in our three patients with acute pancreatitis.

Increased MPV was reported in patients with IBS, compared to controls. This increase in MPV was independent of the type of irritable bowel syndrome \[[@CIT0025]\]. The MPV was lower in patients with active inflammatory bowel disorders in the study by Jaremo and Sandberg-Gertzen \[[@CIT0026]\]. The mean MPV value in 12 patients was 8.12 fl. Increased MPV is associated with cardio-cerebrovascular diseases or low-grade inflammatory conditions such as arterial or venous thrombosis. Familial Mediterranean fever and active rheumatoid arthritis were also found to be associated with lower levels of MPV \[[@CIT0011]\].

Two principal technologies are used to size platelets: aperture impedance and flow cytometry laser optics. The outcome of these tests may have different results. We could not analyse MPV or platelet counts in smoking patients. Also, the current study was retrospective, without any control group. Several variables such as temperature, osmolarity, and pH may affect MPV. Prospective studies are required in larger groups to confirm our data.

Conclusions {#S0007}
===========

Increased or decreased MPV may be associated, without any evidence change, with platelet or WBC counts. The MPV may be a useful, simple, and relatively cheap test to diagnose or differentiate between NSAP and others.
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